Biogen's Early-Stage Alzheimer's Data Continues to Impress Post author:Sam Post published:November 1, 2017 Post category:BioPharma ALZ’s researchers continue to see hope in Biogen’s aducanumab. Source: BioSpace You Might Also Like Sangamo Scores Bragging Rights for First-in-Human Gene Editing Trial November 14, 2017 MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks October 9, 2017 Spotted in the Bay Area: Former FDA Head in Talks to Join Google's Verily May 16, 2017
MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks October 9, 2017
